These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The run on Ritalin. Attention deficit disorder and stimulant treatment in the 1990s. Diller LH Hastings Cent Rep; 1996; 26(2):12-8. PubMed ID: 8722521 [No Abstract] [Full Text] [Related]
6. Association between attention-deficit/hyperactivity disorder and epilepsy in pediatric populations. Hamoda HM; Guild DJ; Gumlak S; Travers BH; Gonzalez-Heydrich J Expert Rev Neurother; 2009 Dec; 9(12):1747-54. PubMed ID: 19951134 [TBL] [Abstract][Full Text] [Related]
7. Race for perfection: children's rights and enhancement drugs. Powers T J Law Health; 1998-1999; 13(1):141-69. PubMed ID: 10788220 [No Abstract] [Full Text] [Related]
10. Attention-deficit hyperactivity disorder. The psychostimulants and beyond. Ludwikowski K; DeValk M Adv Nurse Pract; 1998 Feb; 6(2):55-6, 59-60. PubMed ID: 9555283 [No Abstract] [Full Text] [Related]
11. Use of stimulants for attention deficit hyperactivity disorder: FOR. Coghill D BMJ; 2004 Oct; 329(7471):907-8. PubMed ID: 15485975 [TBL] [Abstract][Full Text] [Related]
12. AAP guideline on treatment of children with ADHD. American Academy of Pediatrics. Chatfield J; Am Fam Physician; 2002 Feb; 65(4):726, 728. PubMed ID: 11871686 [No Abstract] [Full Text] [Related]
13. Use of stimulants for attention deficit hyperactivity disorder: AGAINST. Marcovitch H BMJ; 2004 Oct; 329(7471):908-9. PubMed ID: 15485976 [TBL] [Abstract][Full Text] [Related]
14. Mechanism of action of stimulants in attention-deficit/hyperactivity disorder. Stahl SM J Clin Psychiatry; 2010 Jan; 71(1):12-3. PubMed ID: 20129003 [No Abstract] [Full Text] [Related]
15. A reply to critics of using stimulants to treat attention deficit hyperactivity disorder. Pliszka SR Tex Med; 1991 Apr; 87(4):84-7. PubMed ID: 1674631 [TBL] [Abstract][Full Text] [Related]
16. Advances in the pharmacotherapy of attention-deficit/hyperactivity disorder. Kollins SH; March JS Biol Psychiatry; 2007 Nov; 62(9):951-3. PubMed ID: 17950067 [No Abstract] [Full Text] [Related]
18. Attention-deficit/hyperactivity disorder: are we medicating for social disadvantage? (For). Isaacs D J Paediatr Child Health; 2006 Sep; 42(9):544-7. PubMed ID: 16925542 [TBL] [Abstract][Full Text] [Related]
19. The Society for Developmental and Behavioral Pediatrics Clinical Practice Guideline for the Assessment and Treatment of Children and Adolescents with Complex Attention-Deficit/Hyperactivity Disorder: Process of Care Algorithms. Barbaresi WJ; Campbell L; Diekroger EA; Froehlich TE; Liu YH; O'Malley E; Pelham WE; Power TJ; Zinner SH; Chan E J Dev Behav Pediatr; 2020; 41 Suppl 2S():S58-S74. PubMed ID: 31996578 [No Abstract] [Full Text] [Related]
20. New approaches to the management and treatment of attention-deficit/hyperactivity disorder. Am J Manag Care; 2004 Jul; 10(4 Suppl):S87-8. PubMed ID: 15352534 [No Abstract] [Full Text] [Related] [Next] [New Search]